• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket

    9/2/22 6:26:22 AM ET
    $AMPE
    $APM
    $AVCT
    $BON
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMPE alert in real time by email

    Gainers

    • NewAge, Inc. (NASDAQ:NBEV) shares rose 58.3% to $0.1935 in pre-market trading. NewAge shares tumbled around 47% on Thursday on continued weakness after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • biote Corp. (NASDAQ:BTMD) shares rose 31.3% to $5.79 in pre-market trading. Biote shares started trading after uplisting to the Nasdaq.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 30.8% to $10.86 in pre-market trading after jumping 36% on Thursday. The company priced its IPO at $6.125 per unit.
    • Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) rose 27% to $0.1170 in pre-market trading after declining around 9% on Thursday.
    • PaxMedica, Inc. (NASDAQ:PXMD) rose 20.6% to $4.22 in pre-market trading. PaxMedica Executive Chairman, Director Michael Derby reportED in Form4 filing the purchase of 95,000 shares at $5.25 per share.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 16.4% to $0.2561 in pre-market trading. American Virtual Cloud Technologies shares dropped 52% on Thursday after the company announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) rose 13.5% to $19.25 in pre-market trading. A consortium led by Hollysys Automation’s management is looking to take the US-listed company private in a deal valuing the company at $1.8 billion.
    • Rubicon Technologies, Inc. (NYSE:RBT) rose 13.2% to $5.15 in pre-market trading. The company recently posted a rise in Q2 sales.
    • HashiCorp, Inc. (NASDAQ:HCP) rose 12.3% to $34.00 in pre-market trading after the company posted upbeat Q2 results and issued a strong forecast.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) rose 11.1% to $0.7111 in pre-market trading. Chembio Diagnostics has been awarded a $3.25 million CDC contract.
    • Karyopharm Therapeutics Inc. (NASDAQ:KPTI) rose 10.9% to $5.78 in pre-market trading. Karyopharm Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
    • Lululemon Athletica Inc. (NASDAQ:LULU) rose 9.8% to $323.28 in pre-market trading as the company reported better-than-expected results for its second quarter and boosted its annual projections.
    • Nine Energy Service, Inc. (NASDAQ:NINE) rose 8.9% to $3.32 in pre-market trading after dropping over 8% on Thursday.
    • Pagerduty Inc (NYSE:PD) rose 8.7% to $26.20 in pre-market trading as the company reported stronger-than-expected financial results for its second quarter and increased its guidance for the year.
    • Taoping Inc. (NASDAQ:TAOP) rose 8.4% to $0.7670 in pre-market trading after dropping over 5% on Thursday.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) rose 8.1% to $32.92 in pre-market trading following a 10% drop on Thursday.
    • Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) rose 7.8% to $0.5666 in pre-market trading. The company, last month, posted in-line quarterly earnings.
    • Sigma Lithium Corporation (NASDAQ:SGML) rose 7.8% to $22.95 in pre-market trading after dropping 8% on Thursday.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Addentax Group Corp. (NASDAQ:ATXG) shares fell 44.3% to $16.70 in pre-market trading. Addentax shares tumbled 95% on Thursday following the company's uplisting and IPO.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares fell 35.1% to $34.01 in pre-market trading amid post-IPO volatility.
    • Caladrius Biosciences, Inc. (NASDAQ:CLBS) fell 16% to $0.42 in pre-market trading.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 14.5% to $17.59 in pre-market trading after jumping 47% on Thursday. ShiftPixy announced a 1-for-100 reverse stock split.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) fell 11.6% to $4.92 in pre-market trading after jumping 59% on Thursday.
    • Inspirato Incorporated (NASDAQ:ISPO) fell 10.6% to $2.51 in pre-market trading.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) fell 10.6% to $2.00 in pre-market trading.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) fell 8.3% to $0.33 in pre-market trading.
    • Aptorum Group Limited (NASDAQ:APM) fell 8.2% to $1.33 in pre-market trading after dropping 5% on Thursday.
    • Bon Natural Life Limited (NASDAQ:BON) fell 7.7% to $1.91 in pre-market trading.
    Get the next $AMPE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMPE
    $APM
    $AVCT
    $BON

    CompanyDatePrice TargetRatingAnalyst
    Sigma Lithium Corporation
    $SGML
    4/3/2026$17.00Neutral → Buy
    BofA Securities
    Sigma Lithium Corporation
    $SGML
    4/2/2026$17.00Neutral → Buy
    BofA Securities
    lululemon athletica inc.
    $LULU
    3/18/2026$215.00 → $175.00Market Perform
    Telsey Advisory Group
    PagerDuty Inc.
    $PD
    3/13/2026Outperform → Mkt Perform
    William Blair
    lululemon athletica inc.
    $LULU
    3/12/2026$303.00 → $250.00Buy
    BTIG Research
    Karyopharm Therapeutics Inc.
    $KPTI
    3/10/2026$28.00Buy
    Rodman & Renshaw
    Reviva Pharmaceuticals Holdings Inc.
    $RVPH
    3/5/2026Buy → Hold
    D. Boral Capital
    Karyopharm Therapeutics Inc.
    $KPTI
    2/5/2026Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AMPE
    $APM
    $AVCT
    $BON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF EXECUTIVE OFFICER Zamani Payam bought $59,200 worth of Class A Common Stock (20,000 units at $2.96), increasing direct ownership by 2% to 1,170,000 units (SEC Form 4)

    4 - Inspirato Inc (0001820566) (Issuer)

    8/28/25 4:01:11 PM ET
    $ISPO
    Blank Checks
    Finance

    CHIEF EXECUTIVE OFFICER Zamani Payam bought $11,800 worth of Class A Common Stock (4,000 units at $2.95), increasing direct ownership by 0.35% to 1,150,000 units (SEC Form 4)

    4 - Inspirato Inc (0001820566) (Issuer)

    8/25/25 7:00:15 PM ET
    $ISPO
    Blank Checks
    Finance

    CHIEF EXECUTIVE OFFICER Zamani Payam bought $18,480 worth of Class A Common Stock (6,000 units at $3.08), increasing direct ownership by 0.53% to 1,146,000 units (SEC Form 4)

    4 - Inspirato Inc (0001820566) (Issuer)

    8/20/25 6:26:37 PM ET
    $ISPO
    Blank Checks
    Finance

    $AMPE
    $APM
    $AVCT
    $BON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine's Potential Across Multiple Neuropsychiatric Indications

    CUPERTINO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva," the "Company" "we" or "us"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, PhD, Founder, President, and CEO of Reviva, will participate in a fireside chat hosted by A.G.P. Equity Research Analyst James Molloy on Monday, April 27, 2026 at 11:00 AM ET. The fireside chat will highlight the recent developments from Reviva's clinical stage drug candidate brilaroxazine and upcoming clinical, regulatory

    4/23/26 8:00:00 AM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    lululemon Names Proven Brand Builder Heidi O'Neill as Chief Executive Officer

    O'Neill is a visionary, consumer-focused executive with more than three decades of experience leading brand strategy, product innovation, and operational execution on a global scale lululemon athletica inc. (NASDAQ:LULU) today announced that, following a comprehensive search process, the company's Board of Directors has unanimously approved the appointment of industry veteran Heidi O'Neill as the company's next Chief Executive Officer. Ms. O'Neill will start as CEO and join the Board effective September 8, 2026, and will be based in Vancouver. "Heidi is an inspiring leader and proven, consumer-driven brand strategist, with a rare ability to both imagine a new future for a brand and to c

    4/22/26 4:05:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting

    NEWTON, Mass., April 21, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that its late-breaking abstract was accepted for an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 to June 2 in Chicago. The oral presentation will feature results from the Phase 3 SENTRY trial, a randomized, double-blind, placebo-controlled trial of 60 mg selinexor in combination with ruxolitinib in myelofibrosis.Presentation Details:Title: Selinexor plus ruxolitinib in JAK inhibitor–naïve myelofibrosis: Phase 3 SENTRY trialAbstract Number: LBA6500

    4/21/26 10:32:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPE
    $APM
    $AVCT
    $BON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sigma Lithium upgraded by BofA Securities with a new price target

    BofA Securities upgraded Sigma Lithium from Neutral to Buy and set a new price target of $17.00

    4/3/26 10:44:58 AM ET
    $SGML
    Metal Mining
    Basic Materials

    Sigma Lithium upgraded by BofA Securities with a new price target

    BofA Securities upgraded Sigma Lithium from Neutral to Buy and set a new price target of $17.00

    4/2/26 7:54:43 AM ET
    $SGML
    Metal Mining
    Basic Materials

    Telsey Advisory Group reiterated coverage on lululemon athletica with a new price target

    Telsey Advisory Group reiterated coverage of lululemon athletica with a rating of Market Perform and set a new price target of $175.00 from $215.00 previously

    3/18/26 8:16:55 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    $AMPE
    $APM
    $AVCT
    $BON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Chen Jing Veronica

    3 - Bon Natural Life Ltd (0001816815) (Issuer)

    4/23/26 6:15:32 AM ET
    $BON
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Rangwala Reshma

    4 - Karyopharm Therapeutics Inc. (0001503802) (Issuer)

    4/22/26 4:03:38 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Hu Yongwei

    3 - Bon Natural Life Ltd (0001816815) (Issuer)

    4/10/26 8:07:17 PM ET
    $BON
    Medicinal Chemicals and Botanical Products
    Health Care

    $AMPE
    $APM
    $AVCT
    $BON
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by PagerDuty Inc.

    SCHEDULE 13G - PagerDuty, Inc. (0001568100) (Subject)

    4/23/26 5:16:29 PM ET
    $PD
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFA14A filed by lululemon athletica inc.

    DEFA14A - lululemon athletica inc. (0001397187) (Filer)

    4/22/26 5:23:49 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    SEC Form DEFA14A filed by lululemon athletica inc.

    DEFA14A - lululemon athletica inc. (0001397187) (Filer)

    4/22/26 4:27:26 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    $AMPE
    $APM
    $AVCT
    $BON
    Leadership Updates

    Live Leadership Updates

    View All

    lululemon Names Proven Brand Builder Heidi O'Neill as Chief Executive Officer

    O'Neill is a visionary, consumer-focused executive with more than three decades of experience leading brand strategy, product innovation, and operational execution on a global scale lululemon athletica inc. (NASDAQ:LULU) today announced that, following a comprehensive search process, the company's Board of Directors has unanimously approved the appointment of industry veteran Heidi O'Neill as the company's next Chief Executive Officer. Ms. O'Neill will start as CEO and join the Board effective September 8, 2026, and will be based in Vancouver. "Heidi is an inspiring leader and proven, consumer-driven brand strategist, with a rare ability to both imagine a new future for a brand and to c

    4/22/26 4:05:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Chip Wilson Comments on lululemon's Board Changes and Fourth Quarter and Full Year Fiscal 2025 Results

    VANCOUVER, B.C., March 18, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today issued the following statement regarding the Company's announcement of Board refreshment and fourth quarter and full year results. "As I have communicated publicly and privately for the past several months, lululemon is in dire need of significant and substantial refreshment of the board of directors. Yesterday's announcement that David Mussafer, an overly long-tenured director with more than 14 years of total service on the Board, will not seek re-election, is another step of welcome change. His influence on

    3/18/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Chip Bergh Joins lululemon Board of Directors

    Independent Director Brings Decades of Experience Driving Growth and Value Creation for Iconic Consumer Brands Appointment Reflects Commitment to Ongoing Board Refreshment lululemon athletica inc. (NASDAQ:LULU) today announced the appointment of Chip Bergh, former President and Chief Executive Officer of Levi Strauss & Co., to its Board of Directors, effective immediately. With this addition, lululemon has added five new independent directors to the Board in the last five years, reflecting the Board's commitment to ongoing refreshment. "Chip Bergh is an industry leader with a proven record of guiding successful transformations, overseeing the growth of some of the world's most iconic

    3/17/26 4:05:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    $AMPE
    $APM
    $AVCT
    $BON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PaxMedica Inc.

    SC 13G/A - PaxMedica, Inc. (0001811623) (Subject)

    11/14/24 7:22:38 PM ET
    $PXMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by HashiCorp Inc.

    SC 13G/A - HashiCorp, Inc. (0001720671) (Subject)

    11/14/24 5:45:37 PM ET
    $HCP
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by HashiCorp Inc.

    SC 13G/A - HashiCorp, Inc. (0001720671) (Subject)

    11/14/24 5:42:58 PM ET
    $HCP
    EDP Services
    Technology

    $AMPE
    $APM
    $AVCT
    $BON
    Financials

    Live finance-specific insights

    View All

    Guardforce AI Reports Full Year 2025 Financial Results

    NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ:GFAI, GFAIW)), an AI-driven technology company providing Agentic AI, smart solutions in automation, robotics, and secured logistics, today announced financial results for the year ended December 31, 2025. The Company also updated its business metrics to better reflect its strategic growth strategy and evolving revenue mix. 2025 Operational Highlights In 2025, Guardforce AI advanced its AI transformation by launching self-developed AI agent solutions and driving expansion in smart solutions in Thailand. In the meantime, the Company further strengthened its Secured Logistics

    4/21/26 7:00:00 AM ET
    $GFAI
    Diversified Commercial Services
    Consumer Discretionary

    Guardforce AI Announces Conference Call to Discuss Year-End 2025 Financial Results and Business Update on Tuesday, April 21 at 8:00 A.M. ET

    NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ:GFAI, GFAIW)), an AI-driven technology company providing Agentic AI smart solutions in automation, robotics, and secured logistics, today announced that it will host a conference call at 8:00 a.m. Eastern Time on Tuesday, April 21, 2026, to discuss the Company's financial results for the fiscal year ended December 31, 2025. The call will also include a corporate update covering updated business metrics, recent business developments and strategic progress. Investors and other interested parties may submit questions in advance by emailing: [email protected]. Confere

    4/16/26 8:00:00 AM ET
    $GFAI
    Diversified Commercial Services
    Consumer Discretionary

    Nine Energy Service Announces Timing of First Quarter 2026 Earnings Release and Conference Call

    Nine Energy Service, Inc. (NYSE:NINE) announced today that it has scheduled its first quarter 2026 earnings conference call for Thursday, May 14, 2026, at 9:00 a.m. Central Time. During the call, Nine will discuss its financial and operating results for the quarter ending March 31, 2026, which are expected to be released prior to the conference call. Participants may join the live conference call by dialing U.S. (Toll Free): (877) 524-8416 or International: (412) 902-1028 and ask for the "Nine Energy Service Earnings Call". Participants are encouraged to dial into the conference call ten to fifteen minutes before the scheduled start time to avoid any delays entering the earnings call. F

    4/14/26 5:30:00 PM ET
    $NINE
    Oilfield Services/Equipment
    Energy